Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
31
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Hegde Priti | Director | 6 | $0 | $0 | 2023-06-01 |
| Olagunju Peter | Chief Technical Officer | 23 | $0 | $14.1K | 2023-06-01 |
| Harrison Rosemary | Chief Business & Strategy | 6 | $0 | $0 | 2023-06-01 |
| Hoos Axel | Director | 8 | $0 | $0 | 2023-06-01 |
| MPM Asset Management Investors SunStates Fund LLC | 10% Owner | 1 | $0 | $0 | 2023-06-01 |
| Cardama Alfonso Quintas | Chief Medical Officer | 47 | $0 | $40.3K | 2023-06-01 |
| Justice Angela | Chief People Officer | 40 | $0 | $25.2K | 2023-06-01 |
| Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | 6 | $10.00M | $0 | 2023-06-01 |
| Tomasello Shawn | Director | 8 | $0 | $0 | 2023-06-01 |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | 1 | $0 | $0 | 2023-06-01 |
| Sullivan Eric | Chief Financial Officer | 6 | $0 | $0 | 2023-06-01 |
| Menzel Garry E | President and CEO | 56 | $0 | $101.8K | 2023-06-01 |
| Gibson Neil W | Director | 22 | $0 | $525.3K | 2023-06-01 |
| Webster Stephen W | Director | 8 | $0 | $0 | 2023-06-01 |
| Allen Andrew R | Director | 11 | $0 | $0 | 2023-06-01 |
| TANG CAPITAL PARTNERS LP | 10% Owner | 9 | $797.7K | $0 | 2023-06-01 |
| GADICKE ANSBERT | Director, 10% Owner | 32 | $20.60M | $131.9K | 2023-06-01 |
| MPM ASSET MANAGEMENT LLC | 10% Owner | 4 | $0 | $131.9K | 2023-05-22 |
| TANG KEVIN C | 10% Owner | 2 | $87.6K | $0 | 2023-05-12 |
| Hofmeister Robert | Chief Scientific Officer | 15 | $0 | $884.0K | 2021-12-09 |
| Somaiya Mayur Ian | Chief Financial Officer | 12 | $0 | $180.0K | 2020-12-14 |
| Baeuerle Patrick | Director | 4 | $0 | $1.80M | 2020-12-10 |
| F2 - TPO Investments LLC | 10% Owner | 6 | $0 | $740.3K | 2019-12-20 |
| F2 Capital I 2015 Ltd | 10% Owner | 12 | $0 | $3.61M | 2019-12-11 |
| Globeways Holdings II Ltd | 10% Owner | 13 | $0 | $1.16M | 2019-10-22 |
| F2 MG Ltd | 10% Owner | 12 | $0 | $7.46M | 2019-09-23 |
| F2 Captial I 2017 Ltd | 10% Owner | 14 | $10.00M | $0 | 2019-02-19 |
| MPM SunStates Fund GP LLC | 10% Owner | 5 | $10.60M | $0 | 2019-02-19 |
| China Molybdenum Co., Ltd. | 10% Owner | 5 | $3.00M | $0 | 2019-02-19 |
| Redmile Group, LLC | 10% Owner | 2 | $0 | $0 | 2019-02-19 |
| EVNIN LUKE | 10% Owner | 5 | $10.60M | $0 | 2019-02-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL PARTNERS LP | 10% Owner | J Other | 2023-06-01 | 2024-02-14 | 4,394,800 | — | $0 | 0 | SEC↗ |
| Gibson Neil W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Gibson Neil W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| Gibson Neil W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 8,072 | — | $0 | 0 | SEC↗ |
| Gibson Neil W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Gibson Neil W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 5,000 | — | $0 | 0 | SEC↗ |
| Gibson Neil W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,270 | — | $0 | 0 | SEC↗ |
| Hegde Priti | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Hegde Priti | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 24,968 | — | $0 | 0 | SEC↗ |
| Hegde Priti | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| Hoos Axel | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Hoos Axel | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| Hoos Axel | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 9,596 | — | $0 | 0 | SEC↗ |
| Hoos Axel | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 13,527 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 13,083 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,336 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 78,499 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 1,050 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 76,500 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 23,165 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 15,120 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 3,241 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 238,008 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 39,681 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 433,037 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 138,031 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2023-06-01 | 2023-06-01 | 305,800 | — | $0 | 0 | SEC↗ |
| Harrison Rosemary | Chief Business & Strategy | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,822 | — | $0 | 0 | SEC↗ |
| Harrison Rosemary | Chief Business & Strategy | D To issuer deriv | 2023-06-01 | 2023-06-01 | 76,930 | — | $0 | 0 | SEC↗ |
| Harrison Rosemary | Chief Business & Strategy | D To issuer deriv | 2023-06-01 | 2023-06-01 | 191,102 | — | $0 | 0 | SEC↗ |
| Webster Stephen W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Webster Stephen W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Webster Stephen W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 10,482 | — | $0 | 0 | SEC↗ |
| Webster Stephen W | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| Olagunju Peter | Chief Operating Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 62,047 | — | $0 | 0 | SEC↗ |
| Olagunju Peter | Chief Operating Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,354 | — | $0 | 0 | SEC↗ |
| Olagunju Peter | Chief Operating Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 47,100 | — | $0 | 0 | SEC↗ |
| Olagunju Peter | Chief Operating Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 98,124 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 11,775 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,489 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 9,549 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 1,409 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 31,582 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 114,700 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 90,720 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 42,346 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 70,649 | — | $0 | 0 | SEC↗ |
| Sullivan Eric | Chief Financial Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 40,820 | — | $0 | 0 | SEC↗ |
| Sullivan Eric | Chief Financial Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,804 | — | $0 | 0 | SEC↗ |
| Sullivan Eric | Chief Financial Officer | D To issuer deriv | 2023-06-01 | 2023-06-01 | 250,000 | — | $0 | 0 | SEC↗ |
| Tomasello Shawn | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| Tomasello Shawn | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Tomasello Shawn | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 15,191 | — | $0 | 0 | SEC↗ |
| Tomasello Shawn | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 4,177 | — | $0 | 0 | SEC↗ |
| Allen Andrew R | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| Allen Andrew R | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Allen Andrew R | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 5,000 | — | $0 | 0 | SEC↗ |
| Allen Andrew R | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| Allen Andrew R | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,270 | — | $0 | 0 | SEC↗ |
| Allen Andrew R | Director | D To issuer deriv | 2023-06-01 | 2023-06-01 | 8,072 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer | 2023-06-01 | 2023-06-01 | 48,745 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer | 2023-06-01 | 2023-06-01 | 132,729 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer | 2023-06-01 | 2023-06-01 | 138,871 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer | 2023-06-01 | 2023-06-01 | 132,730 | — | $0 | 0 | SEC↗ |
| Olagunju Peter | Chief Operating Officer | D To issuer | 2023-06-01 | 2023-06-01 | 24,092 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer | 2023-06-01 | 2023-06-01 | 109,459 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | Director, 10% Owner | J Other | 2023-06-01 | 2023-06-05 | 304,001 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | Director, 10% Owner | J Other | 2023-06-01 | 2023-06-05 | 3,854,963 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | Director, 10% Owner | J Other | 2023-06-01 | 2023-06-05 | 3,370,982 | — | $0 | 0 | SEC↗ |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | J Other | 2023-06-01 | 2023-06-05 | 4,158,964 | — | $0 | 0 | SEC↗ |
| MPM Asset Management Investors | 10% Owner | J Other | 2023-06-01 | 2023-06-05 | 4,158,964 | — | $0 | 0 | SEC↗ |
| Oncology Impact Fund (Cayman) | 10% Owner | J Other | 2023-06-01 | 2023-06-05 | 3,370,982 | — | $0 | 0 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-25 | 2023-05-30 | 50,000 | $1.72 | $86.0K | 4,394,800 | SEC↗ |
| GADICKE ANSBERT | Director, 10% Owner | X Exercise deriv | 2023-05-22 | 2023-05-24 | 42,761 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | Director, 10% Owner | X Exercise deriv | 2023-05-22 | 2023-05-24 | 135,508 | — | $0 | 0 | SEC↗ |
| MPM ASSET MANAGEMENT LLC | 10% Owner | X Exercise deriv | 2023-05-22 | 2023-05-24 | 42,761 | — | $0 | 0 | SEC↗ |
| MPM ASSET MANAGEMENT LLC | 10% Owner | X Exercise deriv | 2023-05-22 | 2023-05-24 | 135,508 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | Director, 10% Owner | S Sale | 2023-05-22 | 2023-05-24 | 70,170 | $1.88 | $131.9K | 304,001 | SEC↗ |
| GADICKE ANSBERT | Director, 10% Owner | X Exercise | 2023-05-22 | 2023-05-24 | 178,269 | $0.74 | $131.9K | 374,171 | SEC↗ |
| MPM ASSET MANAGEMENT LLC | 10% Owner | S Sale | 2023-05-22 | 2023-05-24 | 70,170 | $1.88 | $131.9K | 304,001 | SEC↗ |
| MPM ASSET MANAGEMENT LLC | 10% Owner | X Exercise | 2023-05-22 | 2023-05-24 | 178,269 | $0.74 | $131.9K | 374,171 | SEC↗ |
| TANG KEVIN C | 10% Owner | P Buy | 2023-05-12 | 2023-05-15 | 6,183 | $1.95 | $12.1K | 4,344,800 | SEC↗ |
| TANG KEVIN C | 10% Owner | P Buy | 2023-05-11 | 2023-05-15 | 38,765 | $1.95 | $75.6K | 4,338,617 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-10 | 2023-05-10 | 6,774 | $1.95 | $13.2K | 4,299,852 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-09 | 2023-05-10 | 20,141 | $1.95 | $39.3K | 4,293,078 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-08 | 2023-05-10 | 57,073 | $1.95 | $111.3K | 4,272,937 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-05 | 2023-05-05 | 71,064 | $1.94 | $137.9K | 4,215,864 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-05 | 2023-05-05 | 95,759 | $1.90 | $181.9K | 4,144,800 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-04 | 2023-05-05 | 104,241 | $1.86 | $193.9K | 4,049,041 | SEC↗ |
| TANG CAPITAL PARTNERS LP | 10% Owner | P Buy | 2023-05-03 | 2023-05-05 | 18,513 | $1.85 | $34.2K | 3,944,800 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| Tomasello Shawn | Director | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| Harrison Rosemary | Chief Business & Strategy | A Award deriv | 2022-12-15 | 2022-12-19 | 76,930 | — | $0 | 76,930 | SEC↗ |
| Harrison Rosemary | Chief Business & Strategy | A Award deriv | 2022-12-15 | 2022-12-19 | 12,822 | — | $0 | 12,822 | SEC↗ |
| Hegde Priti | Director | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| Hoos Axel | Director | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| Sullivan Eric | Chief Financial Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 40,820 | — | $0 | 40,820 | SEC↗ |
| Sullivan Eric | Chief Financial Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 6,804 | — | $0 | 6,804 | SEC↗ |
| Allen Andrew R | Director | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 16,354 | — | $0 | 16,354 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 98,124 | — | $0 | 98,124 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 13,083 | — | $0 | 13,083 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 78,499 | — | $0 | 78,499 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-12-15 | 2022-12-19 | 39,681 | — | $0 | 39,681 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-12-15 | 2022-12-19 | 238,008 | — | $0 | 238,008 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 70,649 | — | $0 | 70,649 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-12-15 | 2022-12-19 | 11,775 | — | $0 | 11,775 | SEC↗ |
| Menzel Garry E | President and CEO | S Sale | 2022-12-13 | 2022-12-13 | 11,000 | $1.06 | $11.7K | 138,871 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-13 | 2022-12-13 | 1,659 | $1.07 | $1.8K | 24,092 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-13 | 2022-12-13 | 4,752 | $1.06 | $5.0K | 109,459 | SEC↗ |
| Menzel Garry E | President and CEO | S Sale | 2022-12-12 | 2022-12-13 | 10,613 | $1.10 | $11.7K | 149,871 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-12 | 2022-12-13 | 2,963 | $1.06 | $3.1K | 48,745 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-12 | 2022-12-13 | 2,865 | $1.10 | $3.2K | 51,708 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-12 | 2022-12-13 | 1,610 | $1.10 | $1.8K | 25,751 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-12 | 2022-12-13 | 4,586 | $1.10 | $5.0K | 114,211 | SEC↗ |
| Menzel Garry E | President and CEO | S Sale | 2022-12-09 | 2022-12-13 | 10,325 | $1.13 | $11.7K | 160,484 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-09 | 2022-12-13 | 2,792 | $1.13 | $3.2K | 54,573 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-09 | 2022-12-13 | 1,561 | $1.13 | $1.8K | 27,361 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-09 | 2022-12-13 | 4,461 | $1.13 | $5.0K | 118,797 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-08 | 2022-12-09 | 1,410 | $1.25 | $1.8K | 28,922 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-08 | 2022-12-09 | 2,511 | $1.26 | $3.2K | 57,365 | SEC↗ |
| Menzel Garry E | President and CEO | S Sale | 2022-12-08 | 2022-12-09 | 9,314 | $1.25 | $11.6K | 170,809 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-08 | 2022-12-09 | 4,014 | $1.26 | $5.1K | 123,258 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-07 | 2022-12-09 | 1,378 | $1.28 | $1.8K | 30,332 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-07 | 2022-12-09 | 2,457 | $1.28 | $3.1K | 59,876 | SEC↗ |
| Menzel Garry E | President and CEO | S Sale | 2022-12-07 | 2022-12-09 | 9,111 | $1.28 | $11.7K | 180,123 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-07 | 2022-12-09 | 3,928 | $1.28 | $5.0K | 127,272 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-06 | 2022-12-07 | 2,361 | $1.33 | $3.1K | 62,333 | SEC↗ |
| Menzel Garry E | President and CEO | S Sale | 2022-12-06 | 2022-12-07 | 14,886 | $1.35 | $20.1K | 189,234 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-06 | 2022-12-07 | 1,327 | $1.33 | $1.8K | 31,710 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-06 | 2022-12-07 | 3,778 | $1.33 | $5.0K | 131,200 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-05 | 2022-12-07 | 2,302 | $1.37 | $3.2K | 64,694 | SEC↗ |
| Menzel Garry E | President and CEO | S Sale | 2022-12-05 | 2022-12-07 | 8,530 | $1.37 | $11.7K | 204,120 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-05 | 2022-12-07 | 1,291 | $1.37 | $1.8K | 33,037 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-05 | 2022-12-07 | 3,686 | $1.37 | $5.0K | 134,978 | SEC↗ |
| Justice Angela | Chief People Officer | S Sale | 2022-12-02 | 2022-12-05 | 2,273 | $1.39 | $3.2K | 66,996 | SEC↗ |
| Menzel Garry E | President & CEO | S Sale | 2022-12-02 | 2022-12-05 | 8,408 | $1.39 | $11.7K | 212,650 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | S Sale | 2022-12-02 | 2022-12-05 | 1,273 | $1.39 | $1.8K | 34,328 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | S Sale | 2022-12-02 | 2022-12-05 | 3,636 | $1.39 | $5.1K | 138,664 | SEC↗ |
| Justice Angela | Chief People Officer | M Exercise deriv | 2022-12-01 | 2022-12-05 | 50,889 | — | $0 | 13,527 | SEC↗ |
| Justice Angela | Chief People Officer | M Exercise deriv | 2022-12-01 | 2022-12-05 | 5,847 | — | $0 | 6,336 | SEC↗ |
| Justice Angela | Chief People Officer | M Exercise deriv | 2022-12-01 | 2022-12-05 | 2,840 | — | $0 | 1,050 | SEC↗ |
| Menzel Garry E | President & CEO | M Exercise deriv | 2022-12-01 | 2022-12-05 | 21,382 | — | $0 | 23,165 | SEC↗ |
| Menzel Garry E | President & CEO | M Exercise deriv | 2022-12-01 | 2022-12-05 | 40,881 | — | $0 | 15,120 | SEC↗ |
| Menzel Garry E | President & CEO | M Exercise deriv | 2022-12-01 | 2022-12-05 | 158,795 | — | $0 | 3,241 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | M Exercise deriv | 2022-12-01 | 2022-12-05 | 33,409 | — | $0 | 62,047 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | M Exercise deriv | 2022-12-01 | 2022-12-05 | 69,025 | — | $0 | 1,409 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | M Exercise deriv | 2022-12-01 | 2022-12-05 | 17,545 | — | $0 | 6,489 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | M Exercise deriv | 2022-12-01 | 2022-12-05 | 8,815 | — | $0 | 9,549 | SEC↗ |
| Justice Angela | Chief People Officer | M Exercise | 2022-12-01 | 2022-12-05 | 59,576 | — | $0 | 69,269 | SEC↗ |
| Menzel Garry E | President & CEO | M Exercise | 2022-12-01 | 2022-12-05 | 221,058 | — | $0 | 221,058 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | M Exercise | 2022-12-01 | 2022-12-05 | 33,409 | — | $0 | 35,601 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | M Exercise | 2022-12-01 | 2022-12-05 | 95,385 | — | $0 | 142,300 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 10,507 | — | $0 | 10,507 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 31,520 | — | $0 | 0 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 254,847 | — | $0 | 0 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 84,949 | — | $0 | 84,949 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 68,792 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 1,103 | — | $0 | 1,103 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 3,308 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 22,931 | — | $0 | 22,931 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 4,486 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 816 | — | $0 | 816 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 96,514 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 17,548 | — | $0 | 17,548 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 5,799 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 1,933 | — | $0 | 1,933 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 205,503 | — | $0 | 0 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 68,501 | — | $0 | 68,501 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 62,586 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 1,264 | — | $0 | 1,264 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 7,876 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 2,626 | — | $0 | 2,626 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 4,414 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 803 | — | $0 | 803 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 3,791 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 11,380 | — | $0 | 11,380 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 16,398 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 5,466 | — | $0 | 5,466 | SEC↗ |
| Justice Angela | Chief People Officer | D To issuer deriv | 2022-11-17 | 2022-11-18 | 176,850 | — | $0 | 0 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2022-11-17 | 2022-11-18 | 58,950 | — | $0 | 58,950 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-11-17 | 2022-11-18 | 1,167 | — | $0 | 1,167 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2022-11-17 | 2022-11-18 | 240,488 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-11-17 | 2022-11-18 | 821 | — | $0 | 821 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2022-11-17 | 2022-11-18 | 4,512 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-11-17 | 2022-11-18 | 54,834 | — | $0 | 54,834 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2022-11-17 | 2022-11-18 | 164,500 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-11-17 | 2022-11-18 | 43,726 | — | $0 | 43,726 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2022-11-17 | 2022-11-18 | 3,500 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-11-17 | 2022-11-18 | 159,956 | — | $0 | 159,956 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2022-11-17 | 2022-11-18 | 479,866 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2022-11-17 | 2022-11-18 | 2,080 | — | $0 | 2,080 | SEC↗ |
| Menzel Garry E | President and CEO | D To issuer deriv | 2022-11-17 | 2022-11-18 | 6,240 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President & CEO | G Gift | 2022-07-05 | 2022-08-26 | 132,730 | — | $0 | 132,730 | SEC↗ |
| Menzel Garry E | President & CEO | G Gift | 2022-07-05 | 2022-08-26 | 132,730 | — | $0 | 0 | SEC↗ |
| Menzel Garry E | President & CEO | G Gift | 2022-07-05 | 2022-08-26 | 48,202 | — | $0 | 132,729 | SEC↗ |
| Menzel Garry E | President & CEO | G Gift | 2022-07-05 | 2022-08-26 | 48,202 | — | $0 | 132,730 | SEC↗ |
| Menzel Garry E | President & CEO | G Gift | 2022-07-05 | 2022-08-26 | 84,527 | — | $0 | 84,527 | SEC↗ |
| Menzel Garry E | President & CEO | G Gift | 2022-07-05 | 2022-08-26 | 84,527 | — | $0 | 0 | SEC↗ |
| Sullivan Eric | Chief Financial Officer | A Award deriv | 2022-06-27 | 2022-06-27 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Justice Angela | Chief People Officer | A Award | 2022-02-28 | 2022-03-18 | 2,236 | $2.30 | $5.1K | 9,693 | SEC↗ |
| Menzel Garry E | President & CEO | A Award | 2022-02-28 | 2022-03-18 | 1,425 | $2.30 | $3.3K | 180,932 | SEC↗ |
| Harrison Rosemary | Chief Business & Strategy | A Award deriv | 2022-01-10 | 2022-01-12 | 191,102 | — | $0 | 191,102 | SEC↗ |
| Menzel Garry E | President & CEO | M Exercise deriv | 2021-12-10 | 2021-12-10 | 169,054 | $0.74 | $125.1K | 0 | SEC↗ |
| Menzel Garry E | President & CEO | M Exercise deriv | 2021-12-10 | 2021-12-10 | 5,946 | $0.74 | $4.4K | 138,031 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2021-12-09 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| Allen Andrew R | Director | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Hegde Priti | Director | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | A Award deriv | 2021-12-09 | 2021-12-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hoos Axel | Director | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2021-12-09 | 2021-12-10 | 76,500 | — | $0 | 76,500 | SEC↗ |
| Menzel Garry E | President & CEO | A Award deriv | 2021-12-09 | 2021-12-10 | 305,800 | — | $0 | 305,800 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | A Award deriv | 2021-12-09 | 2021-12-10 | 47,100 | — | $0 | 47,100 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2021-12-09 | 2021-12-10 | 114,700 | — | $0 | 114,700 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | M Exercise deriv | 2021-12-09 | 2021-12-10 | 43,000 | $0.74 | $31.8K | 31,582 | SEC↗ |
| Tomasello Shawn | Director | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Menzel Garry E | President & CEO | M Exercise | 2021-12-09 | 2021-12-10 | 175,000 | $0.74 | $129.5K | 179,507 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | M Exercise | 2021-12-09 | 2021-12-10 | 43,000 | $0.74 | $31.8K | 46,915 | SEC↗ |
| Justice Angela | Chief People Officer | A Award | 2021-08-31 | 2021-12-10 | 379 | $14.26 | $5.4K | 7,457 | SEC↗ |
| Menzel Garry E | President & CEO | A Award | 2021-08-31 | 2021-12-10 | 422 | $14.26 | $6.0K | 4,507 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award | 2021-08-31 | 2021-12-10 | 164 | $14.26 | $2.3K | 3,915 | SEC↗ |
| Hegde Priti | Director | A Award deriv | 2021-08-25 | 2021-08-26 | 24,968 | — | $0 | 24,968 | SEC↗ |
| Olagunju Peter | Chief Technical Officer | A Award deriv | 2021-07-26 | 2021-07-27 | 286,367 | — | $0 | 286,367 | SEC↗ |
| Justice Angela | Chief People Officer | M Exercise deriv | 2021-04-02 | 2021-04-02 | 6,752 | — | $0 | 193,248 | SEC↗ |
| Justice Angela | Chief People Officer | M Exercise | 2021-04-02 | 2021-04-02 | 6,752 | $14.81 | $100.0K | 7,078 | SEC↗ |
| Menzel Garry E | President and CEO | A Award | 2021-02-28 | 2021-03-08 | 686 | $16.12 | $11.1K | 4,085 | SEC↗ |
| Justice Angela | Chief People Officer | A Award | 2021-02-28 | 2021-03-08 | 326 | $16.12 | $5.3K | 326 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award | 2021-02-28 | 2021-03-08 | 708 | $16.12 | $11.4K | 3,751 | SEC↗ |
| Tomasello Shawn | Director | A Award deriv | 2021-02-03 | 2021-02-04 | 4,177 | — | $0 | 4,177 | SEC↗ |
| Tomasello Shawn | Director | A Award deriv | 2021-02-03 | 2021-02-04 | 15,191 | — | $0 | 15,191 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | M Exercise deriv | 2020-12-22 | 2020-12-23 | 7,000 | — | $0 | 28,732 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | M Exercise | 2020-12-22 | 2020-12-23 | 7,000 | $0.74 | $5.2K | 45,850 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | M Exercise deriv | 2020-12-14 | 2020-12-16 | 2,000 | — | $0 | 102,558 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | M Exercise | 2020-12-14 | 2020-12-16 | 2,000 | $5.88 | $11.8K | 3,473 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | S Sale | 2020-12-14 | 2020-12-16 | 2,000 | $35.00 | $70.0K | 1,473 | SEC↗ |
| Allen Andrew R | Director | A Award deriv | 2020-12-10 | 2020-12-11 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | A Award deriv | 2020-12-10 | 2020-12-11 | 76,000 | — | $0 | 76,000 | SEC↗ |
| Hoos Axel | Director | A Award deriv | 2020-12-10 | 2020-12-11 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2020-12-10 | 2020-12-11 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Justice Angela | Chief People Officer | A Award deriv | 2020-12-10 | 2020-12-11 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Baeuerle Patrick | Director | A Award deriv | 2020-12-10 | 2020-12-11 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2020-12-10 | 2020-12-11 | 245,000 | — | $0 | 245,000 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2020-12-10 | 2020-12-11 | 101,000 | — | $0 | 101,000 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | A Award deriv | 2020-12-10 | 2020-12-11 | 92,000 | — | $0 | 92,000 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2020-12-10 | 2020-12-11 | 12,100 | — | $0 | 12,100 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | M Exercise deriv | 2020-11-17 | 2020-11-19 | 2,000 | — | $0 | 104,558 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | S Sale | 2020-11-17 | 2020-11-19 | 1,666 | $30.00 | $50.0K | 1,473 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | M Exercise | 2020-11-17 | 2020-11-19 | 2,000 | $5.88 | $11.8K | 5,139 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | S Sale | 2020-11-17 | 2020-11-19 | 2,000 | $30.00 | $60.0K | 3,139 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | M Exercise deriv | 2020-11-12 | 2020-11-13 | 9,998 | — | $0 | 12,348 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | M Exercise deriv | 2020-11-12 | 2020-11-13 | 10,002 | — | $0 | 25,730 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | S Sale | 2020-11-12 | 2020-11-13 | 10,002 | $25.10 | $251.1K | 38,850 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | M Exercise | 2020-11-12 | 2020-11-13 | 9,998 | $0.74 | $7.4K | 48,848 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | S Sale | 2020-11-12 | 2020-11-13 | 9,998 | $25.10 | $250.9K | 38,850 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | M Exercise | 2020-11-12 | 2020-11-13 | 10,002 | $0.74 | $7.4K | 48,852 | SEC↗ |
| Hofmeister Robert | Chief Science Officer | M Exercise deriv | 2020-10-29 | 2020-11-02 | 20,000 | — | $0 | 22,346 | SEC↗ |
| Hofmeister Robert | Chief Science Officer | S Sale | 2020-10-29 | 2020-11-02 | 20,000 | $19.10 | $382.0K | 38,850 | SEC↗ |
| Hofmeister Robert | Chief Science Officer | M Exercise | 2020-10-29 | 2020-11-02 | 20,000 | $0.74 | $14.8K | 58,850 | SEC↗ |
| Menzel Garry E | President and CEO | A Award | 2020-08-31 | 2021-03-08 | 1,132 | $10.10 | $11.4K | 3,399 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award | 2020-08-31 | 2021-03-08 | 1,118 | $10.10 | $11.3K | 3,043 | SEC↗ |
| Webster Stephen W | Director | A Award deriv | 2020-04-30 | 2020-05-04 | 10,482 | — | $0 | 10,482 | SEC↗ |
| Hoos Axel | Director | A Award deriv | 2020-04-13 | 2020-04-15 | 9,596 | — | $0 | 9,596 | SEC↗ |
| Gibson Neil W | Director | S Sale | 2020-03-20 | 2020-03-27 | 648 | $7.94 | $5.1K | 0 | SEC↗ |
| Gibson Neil W | Director | S Sale | 2020-03-19 | 2020-03-27 | 3,140 | $7.41 | $23.3K | 648 | SEC↗ |
| Gibson Neil W | Director | S Sale | 2020-03-18 | 2020-03-27 | 3,120 | $6.83 | $21.3K | 3,788 | SEC↗ |
| Gibson Neil W | Director | S Sale | 2020-03-17 | 2020-03-27 | 3,009 | $6.49 | $19.5K | 6,908 | SEC↗ |
| Gibson Neil W | Director | S Sale | 2020-03-16 | 2020-03-27 | 17,723 | $6.60 | $117.0K | 9,917 | SEC↗ |
| Gibson Neil W | Director | S Sale | 2020-03-13 | 2020-03-27 | 52,000 | $6.52 | $339.0K | 27,640 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | A Award | 2020-02-28 | 2020-03-27 | 1,473 | $10.10 | $14.9K | 3,139 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award | 2020-02-28 | 2020-03-27 | 1,082 | $10.10 | $10.9K | 1,925 | SEC↗ |
| Menzel Garry E | President & CEO | A Award | 2020-02-28 | 2020-03-27 | 1,287 | $10.10 | $13.0K | 2,267 | SEC↗ |
| Baeuerle Patrick | Director | S Sale | 2019-12-23 | 2019-12-26 | 84,907 | $15.44 | $1.31M | 350,786 | SEC↗ |
| F2 - TPO Investments LLC | 10% Owner | J Other | 2019-12-20 | 2019-12-20 | 13,847 | — | $0 | 161,024 | SEC↗ |
| F2 - TPO Investments LLC | 10% Owner | J Other | 2019-12-20 | 2019-12-20 | 586,153 | — | $0 | 713,723 | SEC↗ |
| Baeuerle Patrick | Director | S Sale | 2019-12-20 | 2019-12-26 | 32,022 | $15.16 | $485.5K | 435,693 | SEC↗ |
| Hofmeister Robert | Chief Scientific Officer | A Award deriv | 2019-12-19 | 2019-12-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Somaiya Mayur Ian | Chief Financial Officer | A Award deriv | 2019-12-19 | 2019-12-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Allen Andrew R | Director | A Award deriv | 2019-12-19 | 2019-12-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Menzel Garry E | President and CEO | A Award deriv | 2019-12-19 | 2019-12-20 | 168,000 | — | $0 | 168,000 | SEC↗ |
| Cardama Alfonso Quintas | Chief Medical Officer | A Award deriv | 2019-12-19 | 2019-12-20 | 72,100 | — | $0 | 72,100 | SEC↗ |
| Gibson Neil W | Director | A Award deriv | 2019-12-19 | 2019-12-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| F2 - TPO Investments LLC | 10% Owner | S Sale | 2019-12-19 | 2019-12-20 | 6,642 | $16.47 | $109.4K | 82,575 | SEC↗ |
| F2 - TPO Investments LLC | 10% Owner | S Sale | 2019-12-19 | 2019-12-20 | 35,323 | $16.47 | $581.8K | 155,986 | SEC↗ |
| F2 - TPO Investments LLC | 10% Owner | S Sale | 2019-12-18 | 2019-12-20 | 2,433 | $17.01 | $41.4K | 191,309 | SEC↗ |
| F2 - TPO Investments LLC | 10% Owner | S Sale | 2019-12-18 | 2019-12-20 | 458 | $17.01 | $7.8K | 89,217 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-11 | 2019-12-11 | 4,153 | $17.65 | $73.3K | 1,299,876 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-11 | 2019-12-11 | 1,054 | $17.65 | $18.6K | 330,238 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-11 | 2019-12-11 | 1,381 | $17.65 | $24.4K | 432,319 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-11 | 2019-12-11 | 1,155 | $17.65 | $20.4K | 361,665 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-10 | 2019-12-11 | 30,475 | $17.62 | $537.0K | 1,304,029 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-10 | 2019-12-11 | 7,741 | $17.62 | $136.4K | 331,292 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-10 | 2019-12-11 | 10,135 | $17.62 | $178.6K | 433,700 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-10 | 2019-12-11 | 8,479 | $17.62 | $149.4K | 362,820 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-09 | 2019-12-11 | 75,067 | $17.65 | $1.32M | 1,334,504 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-09 | 2019-12-11 | 19,070 | $17.65 | $336.6K | 339,033 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-09 | 2019-12-11 | 24,966 | $17.65 | $440.6K | 443,835 | SEC↗ |
| F2 Capital I 2015 Ltd | 10% Owner | S Sale | 2019-12-09 | 2019-12-11 | 20,886 | $17.65 | $368.6K | 371,299 | SEC↗ |